One-glance verdict
Undervalued
$22.07 our estimate vs market $4.70
Wall Street consensus: $12.77 (-42.1% lower than our fair-value estimate)
79% below our estimate, below the bear case
Fundamentals snapshot
Nu Skin Enterprises, Inc.
NUS · NYQ · Consumer Defensive · Household & Personal Products
Current price
$4.70
52-week range
$4.45 - $11.67
Market cap
$228.78M
Balance sheet
Watch
6.52x Adequate
Net debt $96.71M. Interest coverage shows how many times profit covers the interest bill.
What stands out
2 Rewards
3 Risks
2 rewards · 3 risks
- Reward Free cash flow was positive in 10/10 years.
- Reward Dividend yield is 5.1% with 26-year payout history.
- Risk Return on equity was -32.5% last year — the company lost money on shareholders' equity.
- Risk Insider ownership is only 3.4% (peer median: 5.0%).
What this company does
Nu Skin Enterprises, Inc.
Nu Skin Enterprises sells beauty and wellness products like skincare devices and supplements. Their money mainly comes from selling these products through a network of independent sellers and online platforms. This business model is important because it relies on building relationships and motivating a large sales force to move their goods globally.
How the company got here
Nu Skin Enterprises was founded in 1984 with a mission to offer innovative beauty and wellness products. It grew by using a direct selling model, where independent representatives market and sell products directly to consumers. This approach allowed the company to expand globally, reaching various international markets. A key part of its strategy has been the development of its 'ageLOC' line, which focuses on anti-aging solutions, aiming to address the biological factors of aging.
What it actually does
Nu Skin Enterprises develops and sells a wide range of beauty and wellness products. Think of it like a company that creates its own brands of skincare gadgets, makeup, and nutritional supplements. These products are designed to help people look and feel younger and healthier. They sell these items through a network of independent salespeople and also online.
Beauty Devices
This part of Nu Skin focuses on high-tech beauty tools that consumers can use at home. Products like the ageLOC LumiSpa and LumiSpa iO are electronic devices designed for skin cleansing and rejuvenation, often working with special creams or serums. The Prysm iO is another example, a wellness device that uses data to personalize user experiences. These devices represent a significant portion of the company's offerings, appealing to consumers looking for advanced skincare solutions.
Skincare Products
This segment includes a variety of cosmetic and personal care items aimed at improving skin health and appearance. It encompasses cleansers, moisturizers, and anti-aging treatments, often designed to be used in conjunction with their beauty devices. Brands like Nu Skin and ageLOC are prominent here, offering solutions for different skin types and concerns. These products are a core part of the company's revenue stream, catering to everyday beauty needs.
Wellness Products
Nu Skin also offers nutritional supplements and other health-focused products under its Pharmanex brand, including items like LifePak and ageLOC TRME. These products are designed to support overall health and well-being, complementing their beauty offerings. This segment taps into the growing consumer interest in health and preventative wellness, providing vitamins, minerals, and other supplements.
What management is betting on now
Nu Skin's management is focused on leveraging digital platforms and innovation to drive future growth. They are investing in technology to enhance the direct selling experience for their independent distributors and to reach a broader customer base online. A key priority is the continued development of their 'ageLOC' anti-aging product line and data-enabled devices, aiming to stay at the forefront of beauty and wellness trends. They are also working to optimize their global operations and supply chain to improve efficiency and responsiveness to market demands.
Price history
How the share price has moved
—
Loading price history…
Earnings history
Last 8 quarters — what happened
Click any quarter to read the call summary and what the numbers say.
FY2024 Q3
$22.84M
FY2024 Q4
$13.20M
FY2025 Q1
$-13.20M
FY2025 Q2
$35.78M
FY2025 Q3
$17.57M
FY2025 Q4
$5.86M
FY2026 Q1
$-17.63M
FY2026 Q2
$4.99M
Revenue
$320.11M
Net income
$-249.80M
Diluted EPS
-5.14
Operating cash flow
$10.62M
Free cash flow
$4.99M
Fetching…
Sources
Revenue
$320.61M
Net income
$1.84M
Diluted EPS
0.04
Operating cash flow
$-3.92M
Free cash flow
$-17.63M
Fetching…
Sources
Revenue
$370.32M
Net income
$14.49M
Diluted EPS
0.27
Operating cash flow
$16.62M
Free cash flow
$5.86M
Fetching…
Sources
Revenue
$364.21M
Net income
$17.08M
Diluted EPS
0.34
Operating cash flow
$27.48M
Free cash flow
$17.57M
Fetching…
Sources
Revenue
$386.14M
Net income
$21.12M
Diluted EPS
0.43
Operating cash flow
$35.80M
Free cash flow
$35.78M
Fetching…
Sources
Revenue
$364.49M
Net income
$107.52M
Diluted EPS
2.14
Operating cash flow
$389.00K
Free cash flow
$-13.20M
Fetching…
Sources
Revenue
$445.55M
Net income
$-36.10M
Diluted EPS
-0.73
Operating cash flow
$25.79M
Free cash flow
$13.20M
Fetching…
Sources
Revenue
$430.14M
Net income
$8.30M
Diluted EPS
0.17
Operating cash flow
$31.43M
Free cash flow
$22.84M
Fetching…
Sources
Is it cheap or expensive?
Fair value $22.07 vs current price $4.70
Wall Street consensus is the average analyst price target: $12.77 (-42.1% lower than our fair-value estimate).
Our most-likely fair value is $22.07 a share — about 369.6% above today's price of $4.70, so the stock currently looks cheap (undervalued).
Is it drowning in debt?
Watch
Net debt $96.7M. Interest coverage 6.5x.
Net debt
$96.71M
Interest coverage
6.52x
Nu Skin Enterprises, Inc.'s profit covers its interest bill about 6.5 times over. which is stronger than most peers shown here and 2 peers sit below 1x, which is the danger zone where profit does not fully cover the interest bill.
Watch
Worse cushion
Baseline
Better cushion
NUS
BASELINE
Nu Skin Enterprises, Inc.
Total debt $288.10M Interest coverage 6.52x This is the baseline the peer rows are being compared against.
Total debt $21.43M Interest coverage 252.48x +3,775% vs NUS Carries about 38.8x more debt cushion than NUS.
Total debt $0.00 Interest coverage 60.41x +827% vs NUS Carries about 9.3x more debt cushion than NUS.
Total debt $20.68M Interest coverage -20.28x -100% vs NUS This peer has almost no interest-payment cushion compared with NUS.
Total debt $9.51M Interest coverage -53.17x -100% vs NUS This peer has almost no interest-payment cushion compared with NUS.
Total debt $2.20B Interest coverage 2.24x -66% vs NUS Carries about 2.9x less debt cushion than NUS.
What you should know
The case for and against NUS
2 Rewards
3 Risks
Rewards
-
Free cash flow was positive in 10/10 years.
-
Dividend yield is 5.1% with 26-year payout history.
Risks
-
Return on equity was -32.5% last year — the company lost money on shareholders' equity.
-
Insider ownership is only 3.4% (peer median: 5.0%).
-
Operating margin compressed from 7.2% to 6.1% over 3 years.
The numbers
All the key metrics, grouped by purpose
Tap any ? icon to learn what it means.
Valuation
How expensive the stock looks
P/E (TTM)
—
Forward P/E
4.05x
P/B
0.42x
P/S
0.17x
EV/EBITDA
2.71x
PEG ratio
0.78x
Profitability
How much profit each dollar creates
Gross margin
69.2%
Operating margin
6.1%
Net margin
-15.7%
ROE
-32.5%
ROA
3.4%
Health
Liquidity and balance-sheet strength
Debt / equity
0.53x
Current ratio
1.98x
Quick ratio
0.94x
Total debt
$288.10M
Total cash
$191.39M
Growth
How the business has been compounding
Revenue TTM
$1.38B
Revenue 5Y CAGR
-13.8%
EPS TTM
-4.43
EPS 5Y CAGR
15.4%
Cash flow
How much cash the business throws off
Operating CF TTM
$50.81M
Free CF TTM
$46.01M
FCF margin
3.3%
Dividend
Shareholder payout
Yield
5.1%
Payout ratio
22.2%
Last ex-div date
2026-08-28